Top Biotechnology Startups in 2027

The protocol enables new economic incentive models for distributed research and development. We leverage open science and blockchain technology to create a fair and accountable market-based platform for discovery and funding of pharmaceutical intellectual property. The ecosystem aims to align all stakeholders - academia, pharmaceutical corporations, consumers, biotech companies, investors, regulators, and lawyers - to collaborate in an open, incentive-based market.

Causaly’s mission is to accelerate the pace of human discovery in biomedicine and to power the research organizations of the world’s largest life sciences companies to accelerate their drug discovery and development programs. We do this by developing easy-to-use AI tools to find and qualify scientific facts and collaborate effectively across multidisciplinary teams. Our technology mimics human reading, and digests tens of millions of scientific documents, clinical trial, labels, news and other data sources at super human scale to generate a high precision Science Knowledge Graph allowing scientists, investigators, researchers and others to answer questions they can’t answer anywhere else.

Neuralink is developing a fully-implanted, wireless, high-channel count brain-machine interface (BMI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease. Neuralink was founded in 2016 by Elon Musk and the company is headquartered in Fremont, CA with a second location opening in Austin, TX.

Headquartered in alameda, california, we are a global healthcare company focused on innovative therapies. we design, develop, manufacture and market novel products and have a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. we sell our products to hospitals and healthcare providers primarily through our direct sales organization in the united states, most of europe, canada and australia, and through distributors in select international markets.

With an expanding portfolio of intellectual property and interdisciplinary technical expertise, Peptineo represents the new face of biotechnology and bioengineering. By employing a systems-based approach, Peptineo technical solutions involve drug delivery combinations including “tunable” nano-carriers, engineered peptides, re-formulated pharmaceuticals, and as appropriate, recombinant proteins. Additionally, Peptineo is developing technologies that will greatly enhance and accelerate the drug discovery process. To that end, we are developing solutions that reflect research efforts in computer science, systems biology, physics, molecular biology, pharmacology, protein engineering and biotechnology. It is our belief that by having a broad range of technology and scientific expertise at our disposal, we will have the resources required to efficiently address current or evolving clinical demands.

Altis Labs is the AI-powered computational imaging company advancing precision medicine. Trained on the world's largest cancer imaging database, our deep learning models predict outcomes to quantify treatment effect more accurately. Leading biopharmaceutical companies use our AI platform, Nota, to analyze clinical trial imaging data in a more meaningful way, allowing them to develop effective novel therapies faster. Founded in 2019, Altis is a venture-backed company headquartered in Toronto. We are actively growing our team in Canada and the US across functional areas.

Vaxess's proprietary technology uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration, unlike existing products. Vaxess strives to lower the cost of distribution and increase access to vaccines for people around the world. - 2013 MassTLC Life Science Technology of the Year - 2013 HBS Alumni New Venture Program Winner - 2012 Harvard Business Plan Competition Winner - 2012 Harvard President's Challenge Winner - 2012 MassChallenge Finalist

Biosimulation: Use computers to better understand the mechanisms of life. - Web-based simulation interfaces: Make your complex simulations easy to use. - Simulation data management: Organize the results of your simulations. - Custom hardware support: Make use of your hardware infrastructure to execute simulations. Big Data: Structure the information of life. - Clinical, pre-clinical and research data management: Organize your data from clinical, pre-clinical, or research studies. - Experimental data, protocol and workflow management: Use the latest tools to tie data to scientific workflows and digitized protocols. - Semantic data management: Use semantic technologies to enable higher order interpretation and analysis of your data. Visualization and data exploration: Gain insight through beautiful interfaces. - Rich web-based visualization dashboards: Use interactive visualizations of your data over the web. - Visualizing scientific data: Get the right perspective on your data.

Axogen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Our comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile and hug—some of the many things healthy peripheral nerves allow us to do.

We are working on building software to enable you to use your brain tomorrow the way you use a mouse and keyboard today, and hardware to enable the next generation of computing.